MEDICAL RESEARCH

FDA fast tracks opioid reversing nasal spray, Narcan, for over-the-counter approval, hoping to combat the fentanyl crisis with this life saving medication.

The Food and Drug Administration relies on preliminary data to make the decision, but asks companies to conduct follow-up studies to confirm that the drug works.

Researchers have discovered a way to delay the decay of tissues and cells after death and even restore function to those cells. This is promising for organ transplant survivability.

UnitedHealth saw an 18% boost in revenue to about $45.1 billion in 2Q. A big reason for the strong quarter was Optum Health's performance. Optum's revenue per customer increased by 30%

CureVac is suing Pfizer's German partner BioNTech for alleged patent infringement related to the development of their mRNA vaccines against COVID-19.

Blackstone Inc. is investing as much as $250 million in U.K. biotechnology company Autolus Therapeutics PLC to fund the final stages of development of a new therapy to treat a serious form of leukemia, the companies said.

The plan to roll out Merck & Co's promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once again at the back of the line, international health groups say.

Shares of Daré Bioscience, Inc., surged 63% ahead of Wednesday's opening bell after the biotech company reported a nearly $49 million grant from The Bill & Melinda Gates Foundation.

A South African girl born with the AIDS virus has kept her infection suppressed for more than eight years after stopping anti-HIV medicines.

Britain's National Cyber Security Center says teams are working "round the clock" to restore hospital computer systems after a global cyberattack that hit dozens of countries forced British hospitals to cancel and delay treatment for patients.

Several British hospitals say they are having major computer problems as the result of an apparent cyberattack.